Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
167 Leser
Artikel bewerten:
(0)

Institute of Life-IASO, EuroMediterranean Institute for Quality and Safety in Health Services and Temos Hellas: Certification of clinical results and success rates of the Institute of Life-IASO Assisted Reproduction Unit

ATHENS, Dec. 9, 2020 /PRNewswire/ -- The Institute of Life-IASO, staying committed to its vision for continuous improvement of its procedures and services, has certified its clinical results and success rates. This certification is the first to be issued in Greece.

(PRNewsfoto/Institute of Life-IASO)

The certified validation of the Institute's statistical measurements and clinical effectiveness indicators once again establishes Institute of Life - IASO as a point of reference to the international scientific community of Assisted Reproduction Centers.

The certification of results was undertaken by the independent body "EuroMediterranean Institute for Quality and Safety in Health Services" and by Temos Hellas, exclusive agent of Temos International Healthcare Accreditation, after a lengthy procedure to validate statistical indicators and success rates for the Unit. The review was conducted by an age group of women who underwent assisted reproduction and in relation to the method applied to achieve pregnancy.

A special standard was developed for the compliance review procedures in accordance with European Union guidelines on criteria to ensure qualitative and objective statistical reporting, international standards for data verification and the principles of the European Statistics Code of Practice and European Commission Regulation 2017/0048 (COD).

Ms Angeliki Katsapi, Executive Director of the EuroMediterranean Institute for Quality and Safety in Health Services and of Temos Hellas, said: "The verification of the Unit's clinical results focuses on the origin of data and the way they are used in publishing statistical reports and, specifically, to the evaluation of their accuracy, transparency, consistency and comparability. I believe that this innovative certification of clinical results should serve as the beginning of more broadly applied certifications in the sector so that every woman, every couple, are able to obtain full and objective knowledge of the services being offered by health providers."

Mr. Eros Nikitos, Director of the Embryology Lab at the Institute of Life-IASO, noted that: "The certified verification of statistical data of our embryology lab demonstrates in the most reliable manner that we remain true to our vision: To offer the greatest possible chance for a couple to realize its dream. Additionally, the qualitative analysis of data allows us to present to each woman, individually, the realistic possibility of achieving pregnancy based on the specific factors present in each unique case."

The sample reviewed by the Institute's expert scientists, and checked, for its compliance with procedures and data reliability specifications, was drawn from the period November 2018 through November 2019 and verification of data for 2020 is already at its final stages.

?bout Institute of Life

Institute of Life, one of the most advanced Assisted Reproduction Centres in Europe, has been created within "Iaso", the largest Obstetrics & Gynecology clinic in Greece and in Southeastern Europe. It was founded by a group of fertility doctors who shared a common dream: to offer patients the best chance of fulfilling their dream of parenthood.

Logo - https://mma.prnewswire.com/media/1362121/Institute_of_life_Logo.jpg

© 2020 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.